Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review

[1] Rodgers RJ(2012)Anti-obesity drugs: past, present and future Dis Model Mech 5 621-6

[2] Tschöp MH(2015)Savings in medical expenditures associated with reductions in body mass index among US adults with obesity, by diabetes status Pharmacoeconomics 33 707-22

[3] Wilding JP(2015)Management of obesity: improvement of health-care training and systems for prevention and care Lancet 385 2521-33

[4] Cawley J(1933)Use of dinitrophenol in obesity and related conditions. A progress report JAMA 101 1472-5

[5] Meyerhoefer C(2011)2,4-dinitrophenol (DNP): a weight loss agent with significant acute toxicity and risk of death J Med Toxicol 7 205-12

[6] Biener A(2005)Anorectics on trial: a half century of federal regulation of prescription appetite suppressants Ann Intern Med 143 380-5

[7] Hammer M(2014)Medical treatment of obesity: the past, the present and the future Best Pract Res Clin Gastroenterol 28 665-84

[8] Wintfeld N(2006)Anti-obesity therapies Nat Rev Drug Discov 5 369-70

[9] Dietz WH(2016)FDA Approved Anti-obesity Drugs in the United States Am J Med 129 879-25

[10] Baur LA(2012)Anti-obesity drugs: a review about their effects and safety Diabetes Metab J 36 13-702

[1] Rodgers RJ(2012)Anti-obesity drugs: past, present and future Dis Model Mech 5 621-6

[2] Tschöp MH(2015)Savings in medical expenditures associated with reductions in body mass index among US adults with obesity, by diabetes status Pharmacoeconomics 33 707-22

[3] Wilding JP(2015)Management of obesity: improvement of health-care training and systems for prevention and care Lancet 385 2521-33

[4] Cawley J(1933)Use of dinitrophenol in obesity and related conditions. A progress report JAMA 101 1472-5

[5] Meyerhoefer C(2011)2,4-dinitrophenol (DNP): a weight loss agent with significant acute toxicity and risk of death J Med Toxicol 7 205-12

[6] Biener A(2005)Anorectics on trial: a half century of federal regulation of prescription appetite suppressants Ann Intern Med 143 380-5

[7] Hammer M(2014)Medical treatment of obesity: the past, the present and the future Best Pract Res Clin Gastroenterol 28 665-84

[8] Wintfeld N(2006)Anti-obesity therapies Nat Rev Drug Discov 5 369-70

[9] Dietz WH(2016)FDA Approved Anti-obesity Drugs in the United States Am J Med 129 879-25

[10] Baur LA(2012)Anti-obesity drugs: a review about their effects and safety Diabetes Metab J 36 13-702